Asser International Sports Law Blog

Our International Sports Law Diary
The Asser International Sports Law Centre is part of the T.M.C. Asser Instituut

The Specificity of Sport - Comparing the Case-Law of the European Court of Justice and of the Court of Arbitration for Sport - Part 2 - By Stefano Bastianon

Editor’s note: Stefano Bastianon is Associate Professor in EU Law and EU sports law at the University of Bergamo and lawyer admitted to the Busto Arsizio bar.


1. EU law and the CAS case-law

Bearing in mind these questions, it is possible to affirm that under EU law, the specificity of sport

i) refers to the inherent characteristics of sport that set it apart from other economic and social activities and which have to be taken into account in assessing the compatibility of sporting rules with EU law; and

ii) under EU law these inherent characteristics of sport must be  considered on a case by case  basis, per the Wouters test as developed by the ECJ in the Meca Medina ruling.

Both aspects can be found in the CAS case-law too, although the CAS case-law shows some remarkable differences and peculiarities. From a general point of view, the application of the principle of specificity of sport in the CAS case-law represents an aspect of the more general issue related to the application of EU law by the CAS. However, the purpose of this paper is not to fully examine if and to what extent the CAS arbitrators apply EU law rules on free movement and competition; rather, the aim is to analyse the way the CAS deals with the concept of the specificity of sport, highlighting similarities and differences compared to the ECJ.

Taking for granted that ‘a CAS panel is not only allowed, but also obliged to deal with the issues involving the application of [EU] law’,[1] as far as the compatibility of sporting rules with EU law is concerned the CAS case-law shows different degrees of engagement. For instance, in the ENIC award concerning the so-called UEFA integrity rule, the CAS panel went through a complete competition-law analysis in perfect harmony with the Wouters et al. ruling by the ECJ.[2] On the contrary, in the above-quoted Mutu case, the issue of compatibility of the FIFA’s transfer regulations with EU competition law was analysed in a rather simple way, merely stating that the FIFA rules at stake were not anti-competitive under EU competition law without giving any reason to support this conclusion. More recently, in the Galatasaray and Milan A.C. awards, concerning the UEFA’s financial fair-play regulations, the CAS  applied a detailed analysis of EU competition law. However, in both cases, according to the CAS the proportionate character of sanctions listed in the UEFA’s financial fair-play regulations cannot affect the evaluation of the legitimacy of these regulations under Art. 101 TFEU. This conclusion represents a clear breaking point with respect to the ECJ case-law, according to which the evaluation of the restrictive effects of a rule necessarily presupposes the analysis of the proportionate character of the sanction imposed in the event of a violation of that rule as well.[3]   In regard to EU free movement, the CAS case-law tends to be less analytical in terms of the principle of proportionality. For instance, in the RFC Seraing award  which concerned both EU free movement and competition law, the CAS panel mainly focused on the legitimate objectives of the contested rule (FIFA’s ban on Third-Party Ownership – TPO), merely affirming that the restrictive measures under EU free movement were justified and inherent in the pursuit of those objectives.More...



The Specificity of Sport - Comparing the Case-Law of the European Court of Justice and of the Court of Arbitration for Sport - Part 1 - By Stefano Bastianon

Editor’s note: Stefano Bastianon is Associate Professor in EU Law and EU sports law at the University of Bergamo and lawyer admitted to the Busto Arsizio bar.*

 

1. Introduction.

The so-called specificity of sport represents one of the most debated, if not the most debated, but still undefined issue under European Union (EU) law. A noteworthy peculiarity is that the specificity of sport is frequently mentioned in several legislative and political documents issued by EU institutions, however it is not expressly referred to in any judgment by the European Court of Justice (ECJ).Conversely, the Court of Arbitration for Sport (CAS) case-law on Art. 17 of FIFA Regulations on status and transfer of players (RSTP) has repeatedly and expressly referred to the specificity of sport.[1] Apparently, the concept of specificity of sport has different meanings and purposes in the ECJ and CAS jurisprudence. In this blog (divided in two parts), I will try to analyse those two different meanings and to what extent the CAS case-law is consistent with the concept of specificity of sport as elaborated under EU law. More...

SFT rejects Semenya appeal: nothing changes - By Andy Brown

Editor's note: Andy Brown is a freelance journalist who has been writing about the governance of sport for over 15 years. He is the editor of The Sports Integrity Initiative where this blog appeared first.


For the last three days, I have been struggling with what to write regarding the Swiss Federal Tribunal’s (SFT) Decision to dismiss a challenge from Caster Semenya and Athletics South Africa (ASA) against the Court of Arbitration for Sport’s (CAS) Decision to dismiss a challenge to the Eligibility Regulations for the Female Classification (Athletes with Differences of Sex Development), otherwise known as the DSD Regulations. From reading World Athletics’ statement welcoming the ruling, one could be forgiven for thinking that it had won a major trial. Sports journalists, accustomed to covering events now curtailed by Covid-19, focus on the fact that Semenya has ‘lost’ her case against the DSD Regulations. Neither assertion is strictly accurate.

The SFT’s powers to review the CAS’s ruling are severely limited. It can only consider whether the CAS Decision violates ‘widely recognised principles of public order’ on Swiss public policy grounds. The SFT has only reversed a decision based on a a violation of Swiss public policy once in 30 years.

The SFT didn’t reconsider the evidence put forward to the CAS. ‘For there to be incompatibility with public policy, it is not enough that the evidence has been poorly assessed, that a finding of fact is manifestly false or that a rule of law has been clearly violated’, its Decision reads. ‘The only question to be resolved is in fact whether or not the verdict of the CAS renders the referred award incompatible with substantive public policy’. 

There were questions about whether the appeal from Semenya and ASA qualified to be reviewed by the SFT in the first place. World Athletics is a private organisation headquartered in Monaco, and the SFT was troubled as to whether such a complaint brought by a South African athlete against an overseas private organisation is capable of violating Swiss public policy.

‘It is doubtful whether the prohibition of discriminatory measures falls within the scope of the restrictive concept of public order when the discrimination is committed by a private person and occurs in relations between individuals’, the Decision quotes from its pervious 29 July 2019 Decision, which refused the ASA’s request to provisionally suspend the application of the DSD Regulations. ‘In any event, there is no need to examine this question further here since […] the award under appeal does not in any way establish discrimination which would be contrary to public order’

The SFT ruled that the CAS was correct to uphold conditions of participation for 46 XY DSD athletes in order to guarantee fair competition for certain disciplines in female athletics. In doing so, the SFT was ruling on whether the decision taken by the CAS violates public policy, based only on the complaints brought forward by Semenya and ASA. 

Semenya and the ASA had challenged the CAS Decision based around the idea that the DSD Regulations are discriminatory. The CAS held that they are discriminatory, but agreed with the IAAF (as World Athletics was then named) that such discrimination was necessary to protect its female category. The SFT ruled that even if the discriminatory rules of a private organisation such as the IAAF were considered able to pose a threat to public order, Semenya and the ASA had failed to demonstrate that the CAS Decision was so egregious that it posed such a threat.

‘Caster Semenya essentially alleges a violation of the prohibition of discrimination’, reads the Swiss Federal Supreme Court statement. ‘The CAS has issued a binding decision based on the unanimous opinion of the experts who were consulted that testosterone is the main factor for the different performance levels of the sexes in athletics; according to the CAS, women with the “46 XY DSD” gene variant have a testosterone level comparable to men, which gives them an insurmountable competitive advantage and enables them to beat female athletes without the “46 XY DSD” variant. Based on these findings, the CAS decision cannot be challenged. Fairness in sport is a legitimate concern and forms a central principle of sporting competition. It is one of the pillars on which competition is based. The European Court of Human Rights also attaches particular importance to the aspect of fair competition. In addition to this significant public interest, the CAS rightly considered the other relevant interests, namely the private interests of the female athletes running in the “women” category.’

Such strong support for the principle behind its DSD Regulations was rightly welcomed by World Athletics. Its statement asserted that the SFT ‘acknowledged that innate characteristics can distort the fairness of competitions’. I would argue that the SFT ruling didn’t do this, but rather found that a CAS Decision asserting this didn’t violate Swiss public policy. Semantics, perhaps.

Likewise, when World Athletics quotes the SFT Decision as confirming that ‘It is above all up to the sports federations to determine to what extent a particular physical advantage is likely to distort competition and, if necessary, to introduce legally admissible eligibility rules to remedy this state of affairs’, it is paraphrasing two texts quoted in the SFT Decision. The first is ‘La qualification juridique des rules autonomes des organizations sportive’ by Jérôme Jaquier, 2004. ‘Inborn characteristics specific to athletes in a particular group can also distort the fairness of competition’, the SFT Decision quotes from Jaquier. ‘When they enact regulations, the objective of sports federations is to ensure fair and equitable competition’.

The context of the second quote, from ‘Sportrecht – Berücksichtigung der Interessen des Sports in der Rechtsordnung’ by Martin Kaiser, 2011, is even more interesting. It is preceded with a statement from the Swiss Federal Supreme Court, which reads: ‘It is not for the Federal Court to make, abstractly, comparisons between the disciplines to assess whether a particular athlete has an advantage that makes sporting competition meaningless’

‘It is above all for the sporting federations to determine to what extent a particular physical advantage is liable to distort competition’, the SFT Decision quotes from Kaiser. ‘And, if so, to establish legally admissible eligibility rules to remedy this state of affairs’. 

Again, such details might be considered as semantics. But – I would argue – important semantics. Reading the media maelstrom that has resulted from the SFT Decision, one could be forgiven for assuming that Semenya has lost her case, and has no chance of ever defending her 800m title. However, a statement issued by her lawyers reveals that she intends to challenge the ruling in European and domestic courts.

“I am very disappointed by this ruling, but refuse to let World Athletics drug me or stop me from being who I am”, the statement continues. “Excluding female athletes or endangering our health solely because of our natural abilities puts World Athletics on the wrong side of history. I will continue to fight for the human rights of female athletes, both on the track and off the track, until we can all run free the way we were born. I know what is right and will do all I can to protect basic human rights, for young girls everywhere.” More...



The Semenya Decision of the Swiss Federal Tribunal: Human Rights on the Bench - By Faraz Shahlaei

Editor's note: Faraz Shahlaei is a JSD Candidate at Loyola Law School, Los Angeles. His research and teaching interests are public international law, international sports law, international human rights and dispute resolution.

 

The issue of international human rights was a central contention in Caster Semenya case ever since the start of her legal battle against the regulations of the IAAF. However, the human rights arguments were poorly considered in the two proceedings related to this case. To put it in perspective, it is like having a key player nailed to the bench throughout the whole game; no coach ever tried to give it a chance while it had the potential to be the game changer for all parties.

In 2019, the Human Rights Council, the inter-governmental human rights body of the UN, expressed concern over issues of discrimination in sports in particular regarding IAAF female classification regulations. In June 2020, the United Nations High Commissioner for Human Rights submitted a report to the United Nations Human Rights Council on the “Intersection of Race and Gender Discrimination in Sport”. The report draws a detailed picture of how human rights in the Semenya case have been violated and also elaborates on the inherent problem of addressing human rights issues in alternative dispute resolution mechanisms favored by the sport governing bodies. However, despite an in-depth discussion of Caster Semenya’s case at both the CAS and then the SFT, the question of human rights, a key concern and a fundamental pillar of the case, hasn’t been adequately answered yet! More...


The SFT’s Semenya Decision under European human rights standards: Conflicting considerations and why a recourse could be successful at Strasbourg - By Kevin Gerenni

Editor's note: Kevin Gerenni is Assistant Professor in Public International Law (Facultad de Derecho de la Universidad de Buenos Aires) and LLM Candidate 2021 in Public International Law at the London School of Economics.


Even though the decision rendered by the SFT in the Semenya Case was foreseeable, the Tribunal did put forward some concerning reasoning in terms of public policy (“ordre public”) and human rights. In case Semenya decides to challenge the Swiss state before the ECtHR, one can expect the case to shake some grounds at the ECtHR, which would be faced with the question of the application to sport not of fair trial guarantees (as in Mutu & Pechstein) but of substantial human rights provisions such as the prohibition of discrimination on the basis of sex (Article 14 ECHR) and the right to private life (Article 8 ECHR).

Under Swiss law, the reasons that may lead to the annulment of an arbitral award are enumerated in art. 190 of the Swiss Private International Law Act (PILA). Semenya’s strongest case relied on art. 190(2)(e): the award’s incompatibility with public policy. Naturally, this point concentrated most of the SFT’s attention. In order to analyze the compatibility of the CAS award with Swiss public policy, the SFT focused on three main potential breaches of human rights: prohibition of discrimination, personality rights, and human dignity. In doing so, it put forward certain observations that differ with European human rights standards and the ECtHR’s jurisprudence. The purpose of this short article is to analyze those discrepancies and, consequently, Semenya’s prospects of success before the Strasbourg Tribunal.More...


Selected procedural issues –and questions– arising out the Caster Semenya Judgment of the Swiss Federal Tribunal - By Despina Mavromati

Editor's note: Dr Despina Mavromati is an attorney specializing in international sports law and arbitration (Sportlegis Lausanne) and a UEFA Appeals Body Member. She teaches sports arbitration and sports contracts at the University of Lausanne, Switzerland

 

As the title indicates, this short note only deals with selected procedural issues and questions arising out of the very lengthy Semenya Judgment. In a nutshell, the SFT dismissed Semenya’s appeal to set aside the CAS Award, which had denied the request of Caster Semenya (Semenya, the Athlete) to declare unlawful the Differences of Sex Development (DSD) Regulations of World Athletics (formerly IAAF).[1]

At the outset, it has to be reminded that the CAS Award dealt with the merits of the Semenya case in a final and binding way by rendering an arbitral award according to Article R59 of the CAS Code (and Article 190 of the Swiss Private International Law Act – PILA). Therefore, the SFT did not act as an appellate court but rather as a cassatory court, entitled to review only whether the exhaustively enumerated grounds for annulment set out in Article 190 (2) PILA were met (and provided that they were properly invoked and substantiated in the motion to set aside said award).More...

Caster Semenya Case Exposes Design Flaws in International Sports Governance - By Roger Pielke Jr.

Editor's note: Roger Pielke Jr. is a professor at the University of Colorado Boulder

 

The decision this week by the Swiss Federal Tribunal not to revisit the arbitral decision of the Court of Arbitration for Sport (CAS) in the case of Caster Semenya was not unexpected, but it does help to expose a major design flaw in international sports governance. Specifically, the institutions that collectively comprise, create and enforce “sports law” appear incapable of addressing flawed science and violations of basic principles of medical ethics.

While different people will have different, and legitimate, views on how male-female competition classifications might be regulated, the issues highlighted involving science and ethics are not subjective, and are empirically undeniable. In normal systems of jurisprudence, procedures are in place to right such wrongs, but in sports governance processes in place prevent such course corrections. And that is a problem.

The empirical flaws in the science underpinning the IAAF (now World Athletics) Semenya regulations are by now well understood, and have been accepted by WA in print and before CAS (I was an expert witness for Semenya, and was present when IAAF accepted responsibility for the flawed research). You can read all the details here and in the CAS Semenya decision. I won’t rehash the flawed science here, but the errors are fatal to the research and obvious to see.

One key part of the comprehensive institutional failures here is that the journal which originally published the flawed IAAF research (the British Journal of Sports Medicine, BJSM) has, inexplicably, acted to protect that work from scrutiny, correction and retraction. Normally in the scientific community, when errors of this magnitude are found, the research is retracted. In this case, the BJSM refused to retract the paper, to require its authors to share their data or to publish a critique of the IAAF analysis. Instead, upon learning of the major errors, the BJSM published a rushed, non-peer reviewed letter by IAAF seeking to cover-up the errors. All of this is non-standard, and a scandal in its own right.

The violation of basic principles of medical ethics required by the implementation of the WA Semenya regulations is also not contested. Both WA and the IOC have claimed to uphold the World Medical Association’s Helsinki Declaration on medical and research ethics. Yet, the WMA has openly criticized the WA regulations as unethical and asked doctors not to implement them. In response, WA has stated that it will help athletes who wish to follow the regulations to identify doctors willing to ignore medical ethics guidelines.

Flawed science and ethical violations are obviously issues that go far beyond the case of Caster Semenya, and far beyond sport. In any normal system of jurisprudence such issues would prove readily fatal to regulatory action, either in the first instance of proposed implementation or via review and reconsideration.

Sport governance lacks such processes. At CAS, the panel claimed that matters of scientific integrity and medical ethics were outside their remit. The SFT is allowed to reconsider a CAS decision only on narrow procedural grounds, and thus also cannot consider matters of scientific integrity or medical ethics. So far then, the flaws in the WA regulations – sitting in plain sight and obvious to anyone who looks, have not been correctable.

This leaves the world of sport governance in a compromised position. Some may look past the scientific and ethical issues here, perhaps judging that barring Semenya from sport is far more important that correcting such wrongs. 

Regardless of one’s views on sex and gender classification in sport, the WA regulations and the processes that produced and have challenged them reveal that sports governance has not yet entered the 21st century. Science and ethics matter, and they should matter in sport jurisprudence as well.  It is time to correct this basic design flaw in international sport governance.

Caster Semenya at the SFT – in 10 points - By Jack Anderson

Editor's note: Jack Anderson is Professor and Director of Sports Law Studies at the University of Melbourne

 

1.     Caster Semenya appealed to the Swiss Federal Court (SFT) arguing that World Athletics’ regulations violated human rights principles relating to gender discrimination and human dignity. The Swiss Federal Tribunal (as at CAS) held that World Athletics’ regulations may prima facie breach such human rights principles but were “necessary, reasonable and proportionate” to maintain fairness in women's athletics;


2.     Although in part addressed at the SFT, expect further legal argument on this in the domestic courts of South Africa or at the ECtHR, and in the following ways:

  • Necessity - is the athletic advantage that Caster Semenya has of such a scientifically-measurable extent that it is necessary for World Athletics to intervene in such an invasive manner? In a broader ethical sense, is the incidence of what the World Athletics’ regulations call “difference of sex development” of such prevalence in the general population, and specifically in middle-distance athletics, that, by way of the principle of “sporting beneficence”, intervention is justified. Or, in contrast, is the incidence of DSD not at a level which justifies a departure from the ethical principle of primum non nocere – first, do no harm?
  • Reasonableness - if World Athletics’ regulations are necessary, is the manner of implementation reasonable and in line with the principle of human and bodily integrity? In answering such a question, the focus must be on the fact that in order to continue to compete in her favourite events (such as the 800 metres) Caster Semenya will have to lower her testosterone level through medication;
  • Proportionate - if World Athletics’ regulations are necessary and reasonable is the manner of implementation proportionate? In answering such a question, the focus must be on whether the regulations disproportionately discriminate against a certain, limited group of athletes in a certain, limited number of events and in a certain, limited manner.More...


Chronicle of a Defeat Foretold: Dissecting the Swiss Federal Tribunal’s Semenya Decision - By Marjolaine Viret

Editor's note: Marjolaine is a researcher and attorney admitted to the Geneva bar (Switzerland) who specialises in sports and life sciences.

 

On 25 August 2020, the Swiss Supreme Court (Swiss Federal Tribunal, SFT) rendered one of its most eagerly awaited decisions of 2020, in the matter of Caster Semenya versus World Athletics (formerly and as referenced in the decision: IAAF) following an award of the Court of Arbitration for Sport (CAS). In short, the issue at stake before the CAS was the validity of the World Athletics eligibility rules for Athletes with Differences of Sex Development (DSD Regulation). After the CAS upheld their validity in an award of 30 April 2019, Caster Semenya and the South African Athletics Federation (jointly: the appellants) filed an application to set aside the award before the Swiss Supreme Court.[1] The SFT decision, which rejects the application, was made public along with a press release on 8 September 2020.

There is no doubt that we can expect contrasted reactions to the decision. Whatever one’s opinion, however, the official press release in English does not do justice to the 28-page long decision in French and the judges’ reasoning. The goal of this short article is therefore primarily to highlight some key extracts of the SFT decision and some features of the case that will be relevant in its further assessment by scholars and the media.[2]

It is apparent from the decision that the SFT was very aware that its decision was going to be scrutinised by an international audience, part of whom may not be familiar with the mechanics of the legal regime applicable to setting aside an international arbitration award in Switzerland.

Thus, the decision includes long introductory statements regarding the status of the Court of Arbitration for Sport, and the role of the Swiss Federal Tribunal in reviewing award issued by panels in international arbitration proceedings. The SFT also referred extensively throughout its decision to jurisprudence of the European Court of Human Rights (ECtHR), rendered in cases related to international sport and the CAS. More...

New Transnational Sports Law Articles Released on SSRN - Antoine Duval

I have just released on SSRN four of my most recent articles on Lex Sportiva/Transnational Sports Law. The articles are available open access in their final draft forms, the final published version might differ slightly depending on the feedback of the editors. If you wish to cite those articles I (obviously) recommend using the published version.

I hope they will trigger your attention and I look forward to any feedback you may have!

Antoine


Abstract: This chapter focuses on the emergence of a transnational sports law, also known as lex sportiva, ruling international sports. In the transnational law literature, the lex sportiva is often referred to as a key example or case study, but rarely studied in practice. Yet, it constitutes an important playground for transnational legal research and practice, and this chapter aims to show why. The focus of the chapter will first be on the rules of the lex sportiva. Law, even in its transnational form, is still very much connected to written rules against which a specific behaviour or action is measured as legal or illegal. As will be shown, this is also true of the lex sportiva, which is structured around an ensemble of rules produced through a variety of law-making procedures located within different institutions. The second section of this chapter will aim to look beyond the lex sportiva in books to narrate the lex sportiva in action. It asks, what are the institutional mechanisms used to concretize the lex sportiva in a particular context? The aim will be to go beyond the rules in order to identify the processes and institutions making the lex sportiva in its daily practice. Finally, the enmeshment of the lex sportiva with state-based laws and institutions is highlighted. While the lex sportiva is often presented as an autonomous transnational legal construct detached from territorialized legal and political contexts, it is shown that in practice it operates in intimate connection with them. Hence, its transnational operation is much less characterized by full autonomy than assemblage.


Abstract: This chapter aims to show that the work of the Court of Arbitration for Sport (‘CAS’), which is often identified as the institutional centre of the lex sportiva, can be understood as that of a seamstress weaving a plurality of legal inputs into authoritative awards. In other words, the CAS panels are assembling legal material to produce (almost) final decisions that, alongside the administrative practices of sports governing bodies (‘SGBs’), govern international sports. It is argued that, instead of purity and autonomy, the CAS’ judicial practice is best characterised by assemblage and hybridity. This argument will be supported by an empirical study of the use of different legal materials, in particular pertaining to Swiss law, EU law and the European Convention on Human Rights (‘ECHR’), within the case law of the CAS. The chapter is a first attempt at looking at the hermeneutic practice of the CAS from the perspective of a transnational legal pluralism that goes beyond the identification of a plurality of autonomous orders to turn its sights towards the enmeshment and entanglement characterising contemporary legal practice.


Abstract: Has the time come for the Court of Arbitration for Sport to go public? This article argues that after the Pechstein decision of the European Court of Human Rights, CAS appeal arbitration must be understood as forced arbitration and therefore must fully comply with the due process guarantees enshrined in Article 6(1) ECHR. In particular, this entails a strong duty of transparency with regard to the hearings at the CAS and the publication of its awards. This duty is of particular importance since the rationale for supporting the validity of CAS arbitration, if not grounded in the consent of the parties, must be traced back to the public interest in providing for the equality before the (sports) law of international athletes. Thus, the legitimacy and existence of the CAS is linked to its public function, which ought to be matched with the procedural strings usually attached to judicial institutions. In short, if it is to avoid lengthy and costly challenges to its awards, going public is an urgent necessity for the CAS.


Abstract: In 1998 the FIFA welcomed the Palestinian Football Association as part of its members - allegedly, as an attempt by then FIFA President, the Brazilian João Havelange, to showcase football as an instrument of peace between Israeli and Palestinians. Ironically, almost 20 years after Palestine’s anointment into the FIFA family, instead of peace it is the conflict between Israeli and Palestinians that moved to FIFA. In recent years the Palestinian Football Association (PFA) and the Israeli Football Association (IFA) have been at loggerheads inside FIFA over the fate - I will refer to it as the transnational legality – of five (and then six) football clubs affiliated to the IFA which are physically located in the Israeli settlements in the Occupied Palestinian Territories (OPT). This chapter chronicles the legal intricacies of this conflict, which will serve as a backdrop to discuss arguments raised regarding the legality of business activities of corporations connected to the Israeli settlements. Indeed, as will be shown in the first part of this chapter, the discussion on the legality of economic activities in the OPT has recently taken a business and human rights turn involving systematic targeting of corporations by activists. Interestingly, we will see that this business and human rights turn also played a role in the conflict between the IFA and the PFA. This case study is therefore an opportunity to examine how the strategy of naming and shaming private corporations, and in our case not-for-profit associations, for their direct or indirect business involvement in the settlements has fared. It is also an occasion to critically assess the strength of the human rights ‘punch’ added to the lex sportiva, by the UNGPs.

Asser International Sports Law Blog | Not comfortably satisfied? The upcoming Court of Arbitration for Sport case of the thirty-four current and former players of the Essendon football club. By James Kitching

Asser International Sports Law Blog

Our International Sports Law Diary
The Asser International Sports Law Centre is part of the T.M.C. Asser Instituut

Not comfortably satisfied? The upcoming Court of Arbitration for Sport case of the thirty-four current and former players of the Essendon football club. By James Kitching

Editor's note: James Kitching is Legal Counsel and Secretary to the AFC judicial bodies at the Asian Football Confederation. James is an Australian and Italian citizen and one of the few Australians working in international sports law. He is admitted as barrister and solicitor in the Supreme Court of South Australia. James graduated from the International Master in the Management, Law, and Humanities of Sport offered by the Centre International d'Etude du Sport in July 2012.


Introduction

On 12 May 2015, the Court of Arbitration for Sport (CAS) announced that the World Anti-Doping Agency (WADA) had filed an appeal against the decision issued by the Australian Football League (AFL) Anti-Doping Tribunal (AADT) that thirty-four current and former players of Essendon Football Club (Essendon) had not committed any anti-doping rule violation (ADRV) identified within the AFL Anti-Doping Code (AADC). The players had each been charged with using Thymosin-Beta 4 (TB4) during the 2012 AFL season.

On 1 June 2015, WADA announced that it had filed an appeal against the decision by the AADT to clear Mr. Stephen Dank (Dank), a sports scientist employed at Essendon during the relevant period, of twenty-one charges of violating the AADC. Dank was, however, found guilty of ten charges and banned for life.

This blog will solely discuss the likelihood of the first AADT decision (the Decision) being overturned by the CAS. It will briefly summarise the facts, discuss the applicable rules and decision of the AADT, review similar cases involving ‘non-analytical positive’ ADRVs relating to the use of a prohibited substance or a prohibited method, and examine whether the Code of Sports-related Arbitration (CAS Code) is able to assist WADA in its appeal.

This blog will not examine the soap opera that was the two years leading-up to the Decision. Readers seeking a comprehensive factual background should view the excellent up-to-date timeline published by the Australian Broadcasting Corporation. 


Factual Background

“Blackest day in Australian sport”

The Decision ultimately derived from what one media commentator dubbed the “blackest day in Australian sport” .

On 7 February 2013, the chief executives of the five biggest Australian sports appeared beside the Federal Sports Minister, Federal Justice Minister, and CEOs of the Australian Sports Anti-Doping Agency (ASADA), and Australian Crime Commission (ACC) at a press conference which detailed the findings of a twelve month inquiry into Australian professional sport. The resulting report, “Organised Crime and Drugs in Sport”, set out that the ACC had identified or suspected widespread use of peptides and hormones in Australian professional sport.

Two days prior, Essendon had requested that ASADA and the AFL investigate whether prohibited substances had been administered to its players during the 2012 season.

AFL disciplinary action

On 2 August 2013, the AFL received an interim report from ASADA and eleven days later charged Essendon and four officers with engaging “in conduct unbecoming or likely to prejudice the interests or reputation of the Australian Football League or to bring the game of football into disrepute”. Essendon and three of the officials were ultimately sanctioned.

The grounds for the charges make for sobering reading. The highlights appear below (emphasis added):

51. With the assistance of Shane Charter (Charter), a convicted drug dealer, Dank ordered various peptides, or the raw materials for such peptides. The compounding of these substances was undertaken by Nima Alavi (Alavi) at the Como Compounding Pharmacy (Como). At least some of these substances were intended by Dank for administration to players at the Club and were in fact administered to players at the Club.

67. On 8 February 2012, at a meeting of players of the Club, Dank introduced four substances that were purportedly approved for use in accordance with the Protocol…

68. Following that meeting, 38 players at the Club signed “Patient Information/Informed Consent” forms in relation to these four substances…

69. If the dosages the subject of the “Patient Information/Informed Consent” forms were administered, the playing group would receive in the order of:

(a) more than 1,500 injections of AOD-9064 and Thymosin; and

(b) more than 16,500 doses of Colostrum; and

(c) more than 8,000 doses of Tribulus.

124. During the relevant period, the Club caused the following substances to be administered to players at the Club:

(a) Actovegin;

(b) unspecified amino acids

(c) unspecified multi-vitamins;

(d) AOD-9604 creams;

(e) AOD-9604 injections;

(f) Cerebrolysin;

(g) Colostrum;

 (h) REDACTED;

(i) Lactaway;

(j) Lube-all-plus;

(k) Melatonin;

(l) Melanotan II;

(m) TA-65;

(n) Thymosin Beta 4;

(o) Traumeel; and

(p) Tribulus.

125. The use of these substances by the players was not approved by the Club’s medical staff, with the exception of AOD-9604, which was the subject of some sort of informal approval by Reid in February 2012.

126. In many instances the use of these substances failed to have proper regard to player health and safety.

127. Proper records were not maintained by the Club as to precisely which players received which of the substances referred to in paragraph 124 above, in which quantities and when, during the relevant period.


AFL Anti-Doping Tribunal

Applicable Rules

On 14 November 2014, the AFL issued identical infraction notices to the 34 players alleging use of the prohibited substance TB4 during the 2012 season in violation of Article 11.2 of the AADC. The players were provisionally suspended on the same day. The infraction notices were issued after the players were placed on the ADRV Register of Findings on 12 November 2014 by an independent Anti-Doping Rule Violation Panel pursuant to the National Anti-Doping Scheme prescribed in the Australian Sports Anti-Doping Authority Act 2006.

As the alleged misconduct occurred during the 2012 AFL season, the applicable version of the AADC was the 2010 edition. This version was effectively a mirror of the WADA Code 2009.

As such, the standards applied universally by sports disciplinary and anti-doping panels applied. Accordingly, AFL and/or ASADA bore the burden of proving each ADRV to the comfortable satisfaction of the AADT, bearing in mind the seriousness of each allegation made. Such standard of proof was greater than a mere balance of probability, but less than beyond a reasonable doubt.[1] The AFL and/or ASADA were able to establish the allegations by “any reliable means”.[2]

Decision

The hearing was conducted on various dates between December 2014 and February 2015. The Decision was announced on 31 March 2015. However, its written reasons have never been made public. As such, determining the evidence that was available has been gleaned from numerous media reports (including this comprehensive piece by Gerard Whateley), public announcements, and leaked documents. The author has also had the benefit of discussing the matter with a number of parties close to the proceedings.

It was agreed by the parties that the case against each player had two limbs:

(i)           during the 2012 AFL season, the player used (through injections) TB4; and

(ii)          TB4 was a prohibited substance on the relevant WADA Prohibited List.

As a threshold issue, the AADT was comfortably satisfied that TB4 was a prohibited substance within the category of substances set out in s2 of the 2012 WADA Prohibited List:

any pharmacological substance which is not addressed by any of the subsequent sections of the list and with no current approval by any governmental regulatory health authority for human therapeutic use”.

Thus, the case turned on the ability of ASADA to discharge its burden of proof relating to the first limb. This limb was broken down into three elements, agreed by the parties, which formed the basis of the ASADA case:

(a)          TB4 was procured from sources in China;

(b)          TB4 was obtained by Alavi, compounded and provided to Dank in his   capacity as Sports Scientist at Essendon; and

(c)           Dank administered TB4 to each player.

This was essentially the same conduct, described above, for which Essendon and its four officials were sanctioned.

Charter, Alavi and Dank all refused to appear at the hearing, and ASADA failed in a last-ditch application to the Victorian Supreme Court to compel Charter and Alavi to appear pursuant to the Commercial Arbitration Act 2011.[3] As such, ASADA’s case was wholly circumstantial, and relied, in a large part, on testimony and documents provided to it by Charter and Alavi during its investigation, and statements made by Dank in the media.

The AADT thus had an unenviable task in determining the probative value of the evidence provided by key witnesses without having the benefit of observing them under examination and cross-examination. As such, the AADT held (emphasis added):

“Having considered all the evidence relating to the credibility and reliability of Mr Alavi, Mr Charter and Mr Dank … the Tribunal finds that the credibility of each of these principal participants is at a low ebb and each man in acting as he did in his own way and for his own motive saw a golden opportunity to “feather his own nest.” Their lack of credibility is reflected when their reliability is called into question and the Tribunal is satisfied that on a number of important issues their evidence on those issues was not only unreliable but also … dishonest.

In the absence of reliable direct evidence to establish that the players had used TB4, the decision of the AADT ultimately turned on these adverse credibility findings.

In relation to the first element, ASADA led (predominantly) documentary evidence to demonstrate that two shipments of substances (in December 2011 and February 2012) were procured from China, both of which included TB4, and were provided to Alavi. A substance in the second shipment was tested in May 2012 at a laboratory connected to the University of Melbourne, and the results proved the substance was TB4. As such, the substance that was purported to be TB4 in both shipments, as a result of the test results, was TB4.

After a thorough examination of the evidence and arguments of the players, and in particular, the fact that the majority of evidence had been obtained from dishonest witnesses, the AADT held that the first shipment had occurred, but that the second shipment had not. However, the AADT still considered the veracity of the test results, and whether they gave rise to the position that TB4 was procured in the first shipment. Faced with contrasting expert reports, which gave margin for error in the test results, the AADT ultimately held that “it is possible it was [TB4], but the Tribunal is not comfortably satisfied that it was”.

In relation to the second element, the AADT was not comfortably satisfied that TB4 was compounded or provided to Dank. As a result of its findings relating to the first and second elements, the AADT did not “consider it necessary to consider the third element…as it is dependent upon the first and second elements…being established and neither has been established to the comfortable satisfaction of the Tribunal”.

Accordingly, the AADT was not comfortably satisfied that the first limb required to prove the ADRV was made out, and exonerated each player of their charge.


Non-analytical positive “use”

The Decision is a classic non-analytical positive “use” case.[4] In this class of cases, as no adverse analytical finding is recorded, the relevant anti-doping organisation must rely on a combination of direct and/or circumstantial evidence in order to discharge its burden of proving use of a prohibited substance or method.

Comfortable Satisfaction

Prior to the implementation of the WADA Code, sports arbitration panels embryonically decided to apply a ‘comfortable satisfaction’ standard of proof; less than the criminal standard of proof beyond a reasonable doubt but more than the ordinary civil standard of proof on the balance of probabilities.[5]

This standard was preferred due to sports disciplinary cases not being criminal in nature, but rather, a private law of association type.[6] This principle has been consistently upheld and was espoused as such by the Swiss Federal Tribunal: “the duty of proof and assessment of evidence [are] problems which cannot be regulated, in private law cases, on the basis of concepts specific to criminal law”.[7]

However, precisely where this standard falls between the criminal and civil standards is unclear.[8] That anti-doping cases are presented in a quasi-criminal manner suggests they should be closer to the latter, but the private nature of sports disciplinary cases suggests that the lesser standard is more appropriate.

This distinction is significantly important to WADA overturning the Decision. In its press release after receiving the Statement of Appeal, the CAS recorded that “WADA requests that the CAS issue a new decision based on an appropriate burden of proof and evidentiary standards”. As such, it is clear that WADA considers that the standard of proof applied by the AADT was too high when considering the evidence.

However, an analysis of a number of prior decisions suggests that the standard of proof in this class of cases has always been close to the criminal standard. The jurisprudence suggests that Panels rely solely on direct and incontrovertible testimonial, documentary, and scientific evidence to sanction individuals for “use” violations.


pre WADA Code cases

In French[9], it was alleged that French used prohibited substances after the discovery of a bucket of used syringes, needles containing traces of a prohibited substance, and a supplement whose label stated that it contained a prohibited substance, inside his room at his athlete residence. The CAS, however, was not comfortably satisfied as there was “no direct evidence that Mr. French had used the material in the sense that no-one saw him use it and he has consistently denied use”.[10] Furthermore, that the label stated the name of the prohibited substance was not sufficient to prove that the supplement actually contained the prohibited substance.[11]

In A., B., C., D., E. v IOC[12], five simultaneously-decided cases, the CAS held that admissions of undertaking or performing blood transfusions, coupled with the discovery of instruments and chemicals necessary for blood-doping in their residence during the 2002 Winter Olympics, was sufficient evidence to sanction four individuals for using a prohibited method. In the absence of direct evidence against Mr. E, the only of the five whom argued that “he had nothing to do with the paraphernalia found in the chalet and that he did not perform any type of autologous or other blood manipulation while he was at the 2002 Winter Games[13], the Panel issued a warning only.[14]

In Collins[15], a case deriving from the BALCO scandal, the United States Anti-Doping Agency (USADA) relied on a cache of emails where Collins admitted to using prohibited substances (both EPO and the hybrid testosterone “cream” developed by BALCO)[16], as well as test results of independent blood and urine tests arranged by BALCO.[17] Following expert testimony, the Panel found beyond a reasonable doubt (as was required by the relevant IAAF Rules) that her blood samples demonstrated EPO use in 2002 and 2003[18] and that her urine samples demonstrated “a pattern of testosterone and epitestosterone levels that can only be explained by the illegal use of BALCO’s cream”.[19]


post WADA Code cases

In Gaines[20] and Montgomery[21], two further BALCO cases heard simultaneously, following argument on the appropriate standard, the Panels stated: (emphasis added)

From this perspective, and in view of the nature and gravity of the allegations at issue in these proceedings, there is no practical distinction between the standards of proof advocated by USADA and the Respondents. It makes little, if indeed any, difference whether a “beyond reasonable doubt” or “comfortable satisfaction” standard is applied to determine the claims against the Respondents. This will become all the more manifest in due course, when the Panel renders its awards on the merits of the USADA’s claims. Either way, USADA bears the burden of proving, by strong evidence commensurate with the serious claims it makes, that the Respondents committed the doping offences in question”.[22]

Similar to Collins, the USADA relied on a multitude of testimonial, documentary and scientific evidence to allege use of a prohibited substance. However, the Panel ultimately decided that admissions about their use of the infamous “Cream” developed by BALCO to their ex-teammate Kelli White, was “sufficient in and out of itself[23] to comfortably satisfy themselves of the athletes’ guilt.

In Hamilton[24], the Panel cited the discussion of the appropriate standard referred to in Gaines and Montgomery but did not explicitly apply it.[25] After upholding the reliability and validity of the homologous transfusion test of Hamilton’s blood samples, the Panel relied upon these test results to be comfortably satisfied that Hamilton had used a prohibited method.[26] A similar approach was undertaken by the Panel in Pechstein[27] to find that %retics peaks in her blood sample of February 2009 were abnormal and that accordingly she had used a prohibited method.

In the Cyprus case[28], WADA and FIFA appealed a decision of the Cyprus Football Association (CFA). Prior to a number of league matches, a club coach administered two pills (which he had independently sourced) to the starting line-up, claiming them to be caffeine pills and/or vitamins.[29] Two players subsequently recorded an adverse analytical finding for a prohibited substance, while five others who did not test positive admitted to investigators that they had also used the pills. Only the two players and the coach were sanctioned by the CFA. WADA alleged that the CFA had erroneously failed to sanction the five players. The Panel was not comfortably satisfied of this conclusion:

199. The Panel notes, in fact, that there is no evidence that the actual pills individually used by each of the Other Players contained a prohibited substance. Indeed some players took the pills, were subsequently tested and there was no adverse analytical finding.

200. No clear cut evidence was brought to show that…the pills administered…were “plain steroids” and not “caffeine pills” contaminated by steroids”.[30]

The most famous case in this class, albeit never reviewed by an arbitration panel, was Armstrong.[31] The USADA relied on witness testimony which provided direct evidence of Armstrong using prohibited substances or prohibited methods during the 1999, 2000, 2002, 2003, 2004, and 2005 Tour de France races. The USADA also utilised financial records linking Armstrong to the disgraced sports doctor, Dr. Michele Ferrari, as well as undertaking retesting of old samples which purportedly demonstrated EPO use at the 1999 Tour de France, and provided a “compelling argument consistent with blood doping” at the 2010 Tour de France.


Conclusions

Two overriding conclusions can be drawn.

The first is that there is no definitive answer to the question of what evidence shall be presented to prove a non-positive analytical “use” case.[32] As stated by the Panels in Gaines and Montgomery:

[d]oping offences can be proved by a variety of means; and this is nowhere more true than in “non-analytical positive” cases such as the present”.[33]

The second is that the standard of proof is significantly closer to the criminal than the civil standard. Indeed, in Gaines and Montgomery, the Panels could draw no distinction between beyond a reasonable doubt and comfortable satisfaction, taking into account the allegations raised and the sanctions requested. This elevated standard becomes clear in those matters which relied solely upon circumstantial as opposed to direct evidence.

In French and the Cyprus case, the Panels held that admissions could be relied upon only where there was unambiguous evidence that the substance used either was or contained a prohibited substance. Thus, a label on supplement packaging which lists a prohibited substance as an ingredient, or the ingestion of a pill taken from the same batch as one ingested by a teammate who subsequently tests positive, are not enough on their own to comfortably satisfy a Panel that a used substance was a prohibited substance.

Effectively, the cases require the party bearing the evidentiary burden to prove that the used substance or method was without doubt the substance or method alleged; in other words, the highest possible standard of ‘comfortable satisfaction’. Even in Pechstein, where the Panel emphatically rejected the Appellant’s request to apply a higher than normal standard of proof and stated that it would apply the “normal comfortable satisfaction standard”,[34] the Panel still blurred the lines between the two after systematically reviewing and rejecting each of the Appellant’s argument, leaving little doubt in its own mind that the use of a prohibited method was the only possible reason for the blood abnormalities.

To meet this standard, the cases articulate that only direct evidence should be adduced. This includes: admitting to using a proven prohibited substance or prohibited method; scientific evidence of which no credible explanation other than the use of a prohibited substance or prohibited method is possible; scientific evidence which demonstrates that a substance used is a prohibited substance; witness observations of use; and witness testimony of direct admissions.

One further conclusion can be drawn: WADA, on the basis of its current evidence, is unlikely to overturn the Decision. The inherited ASADA case was wholly circumstantial. It did not contain direct, incontrovertible evidence from any of the classes seen in the previous cases. Its key witnesses chose not to testify, nor could they be compelled under Australian law, and nor is it likely that they can be compelled under Swiss law to attend at the CAS.[35] As such, WADA’s prospects of success hinge upon its ability to adduce new and direct evidence of the use of TB4 by the players. 


Will R57.3 of the CAS Code prevent WADA from adducing new and direct evidence?

R57 of the CAS Code provides that a Panel in the appeal arbitration division has “full power to review the facts and the law”. Appeals are heard de novo and any procedural fairness issues deriving from the first-instance are thus automatically cured. This interpretation has been upheld in numerous Awards and the Swiss Federal Tribunal.[36]

R57.3 of the CAS Code, introduced in 2013, provides one limitation: “[t]he Panel has the discretion to exclude evidence presented by the parties if it was available to them or could reasonably have been discovered by them before the challenged decision was rendered”. This is consistent with Swiss procedural law in that a document can only be adduced, at an appellate hearing, if it did not exist at the time of the first instance hearing or hearings or was not in the possession of the appellant at the time.[37]

According to Rigozzi et al, in appeals against decisions rendered by sports-governing bodies, the scope of R57.3 should extend only to those cases “where the adducing of pre-existing evidence amounts to abusive or otherwise unacceptable procedural conduct by a party”.[38]

Mavromatis characterises de novo review as “not only desirable, but also necessary for a number of reasons, to the extent that the previous instance is not an independent arbitral tribunal but the internal body of a sports federation”.[39] As such, R57.3 should be interpreted “as not to circumvent the core principle of the Panel’s full power of review[40].

In two recent Awards, the Panels held that this discretion should be exercised with caution, in situations where a party may have engaged in abusive procedural behaviour or in any other circumstances where the Panel might, in its discretion, consider it either unfair or inappropriate to admit new evidence.[41]

In SC FC Sportul Studentesc SA[42], the Sole Arbitrator excluded the principal evidence supporting the appeal as he was not provided any satisfactory explanation why it could not be submitted or adduced during the two sports-governing body proceedings.[43]

Hence, it is only in rare cases that the CAS limits its power of full review. Thus, as long as new evidence adduced by WADA is neither abusive nor can be construed as unacceptable procedural conduct, it is highly unlikely to be excluded. Levy has suggested that such exclusions may give rise to an appeal to the Swiss Federal Tribunal due to the denial of the right to be heard.[44] In any event, WADA was not a party at first instance, so it remains questionable whether R57.3 may even be utilised by the players. 


Conclusion

The biggest soap opera in the history of Australian sport will come to a conclusion some time prior to the 2016 AFL season. At the time of publishing, the CAS has recently announced the hearing timeline.

Media reports have recently suggested that WADA ordered retesting of samples obtained from the players in 2011-2012, resulting in two samples demonstrating abnormally high levels of TB4. As set out above, the previous cases suggest that only this type of direct evidence will be able to convince a Panel to the requisite standard. The challenge for WADA, given the length of the ASADA investigation, is to find it.

An independent report commissioned by Essendon published in May 2013, graphically described its supplements programme as “a pharmacologically experimental environment never adequately controlled or challenged or documented within the Club in the period under review”. It is not disputed that the players must ultimately take full responsibility for each substance that presents in their body.

However, at the same time, the gross inadequacies in the governance at Essendon during the period – failures in documentation and record keeping, lack of (proper) informed consent for the players, uncertainty in the supplements administrated, and the creation of an unsafe work environment, among others – for which the club was already heavily sanctioned and which gave rise to the investigation in the first place, ironically appears to be the main obstacle preventing WADA from discharging its burden of proof.



[1] AFL Anti-Doping Code (2010 Edition), Article 15.1.

[2] AFL Anti-Doping Code (2010 Edition), Article 15.1.

[3] ASADA v 34 Players and One Support Person [2014] VSC 635. 

[4] See e.g. Richard H McLaren, An Overview of Non-Analytical Positive & Circumstantial Evidence Cases in Sports, 16 Marq. Sports L. Rev. 193 (2006).

[5] See e.g. N., J., Y., W. v Federation Internationale de Natation CAS 98/208.

[6] Ibid.

[7] SFT, 5P83/1999, para. 3.d.

[8] Michael Straubel, Enhancing the Performance of the Doping Court: How the Court of Arbitration for Sport Can Do Its Job Better, 36 Loy. U. Chi. L. J. 1203 (2005), at 1270.

[9] Mark French vs Australian Sports Commission and Cycling Australia, CAS 2004/A/651.

[10] French at 58.

[11] French at 51.

[12] A., B., C., D. & E. v International Olympic Committee, CAS 2002/A/389, 390, 391, 392, 393.

[13] A., B., C., D. & E. v IOC at 53.

[14] A., B., C., D. & E. v IOC at 53.

[15] United States Anti-Doping Agency vs Michelle Collins, AAA No. 30 190 00658 04.

[16] Collins at 1.3, 4.1, 4.2, 4.3, 4.4.

[17] Collins at 1.3, 4.11 – 4.24.

[18] Collins at 4.16.

[19] Collins at 4.17.

[20] United States Anti-Doping Agency vs Chryste Gaines, CAS 2004/O/649.

[21] United States Anti-Doping Agency vs Tim Montgomery, CAS 2004/O/645

[22] Gaines at 36, Montgomery at 36.

[23] Gaines at 52, Montgomery at 50.

[24]Tyler Hamilton vs United States Anti-Doping Agency and Union Cycliste International, CAS 2005/A/884.

[25] Hamilton at 47.

[26] Hamilton at 91.

[27] Claudia Pechstein vs International Skating Union, CAS 2009/A/1912.

[28] World Anti-Doping Agency and Federazione International de Football Association v Cyprus Football Association, Carlos Marques, Leonel Medeiros, Edward Eranosian, Angelos Efthymiou, Yiannis Sfakianakis, Dmytro Mykhailenko, Samir Bengeloun, Bernardo Vasconcelos, CAS 2009/A/1817.

[29] WADA & FIFA v CFA et al at 14.

[30] WADA & FIFA v CFA et al at 198-200.

[31] United States Anti-Doping Agency vs Lance Armstrong, Reasoned decision of the USADA on disqualification and eligibility (10 October 2012).

[32] McLaren at 212.

[33] Gaines at 45, Montgomery at 45.

[34] Pechstein at 123-126.

[35] See this piece for an excellent analysis of the operation of the powers of compulsion within the Swiss Public International Law Act vis-à-vis Australian law: < http://sociallitigator.com/2015/05/25/essendon-supplements-saga-is-it-up-up-and-away-to-switzerland/>.

[36] see FC Sion v Federation Internationale de Football Association & Al-Ahly Sporting Club, CAS 2009/A/1880; E v Federation Internationale de Football Association, CAS 2009/A/1881; Eintracht Braunschweig GmbH & Co. KG a. A. v. Olympiakos FC CAS 2012/A/2836; SFT 4A_386/2010

[37] Article 317 of the Swiss Civil Procedure Code.

[38] Antonio Rigozzi /Erika Hassler / Brianna Quin, The 2011, 2012 and 2013 revisions to the Code of Sports-related Arbitration, in: Jusletter 3 juin 2013, at 14.

[39] Despina Mavromatis, The Panel’s Right to Exclude Evidence Based on Article R57 Para. 3 CAS Code: a Limit to CAS’ Full Power of Review, in CAS Bulletin 1/2014, at 56.

[40] Mavromatis at 56.

[41] See Zamalek Sporting Club vs Accra Hearts of Oak Sporting Club, CAS 2014/A/3518; MFK Dubnica v FC Parma, CAS 2014/A/3486.

[42] SC FC Sportul Studentesc SA v Romanian Football Federation & several players, CAS 2013/A/3286-3294.

[43] SC FC Sportul Studentesc SA at 66-70.

[44] Roy Levy, The new CAS rules – what you need to know, at < http://www.lawinsport.com/blog/roy-levy/item/the-new-cas-rules-what-you-need-to-know>.

Comments (1) -

  • sam ciccarello

    9/16/2015 3:46:05 AM |

    Very well written and presented.

    Consider your conclusion to be rational and compelling.

    Look forward to your follow up blog when the Decision is made public.

Comments are closed